

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane organization (GO:0097090) | 5.54301378 |
| 2 | presynaptic membrane assembly (GO:0097105) | 5.26810542 |
| 3 | somite development (GO:0061053) | 4.43074312 |
| 4 | embryonic foregut morphogenesis (GO:0048617) | 4.21772259 |
| 5 | hemidesmosome assembly (GO:0031581) | 4.00865322 |
| 6 | neuronal stem cell maintenance (GO:0097150) | 3.73320538 |
| 7 | vocalization behavior (GO:0071625) | 3.73180661 |
| 8 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.65928507 |
| 9 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.55866707 |
| 10 | lateral sprouting from an epithelium (GO:0060601) | 3.55025221 |
| 11 | * negative chemotaxis (GO:0050919) | 3.53521388 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 3.53364864 |
| 13 | otic vesicle formation (GO:0030916) | 3.44175768 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.43554832 |
| 15 | postsynaptic membrane organization (GO:0001941) | 3.40321049 |
| 16 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.37334868 |
| 17 | negative regulation of amino acid transport (GO:0051956) | 3.36998182 |
| 18 | protein localization to synapse (GO:0035418) | 3.31984810 |
| 19 | retinal ganglion cell axon guidance (GO:0031290) | 3.30116555 |
| 20 | neuron fate determination (GO:0048664) | 3.28119778 |
| 21 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.21600993 |
| 22 | axon extension involved in axon guidance (GO:0048846) | 3.21600993 |
| 23 | membrane assembly (GO:0071709) | 3.19832072 |
| 24 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.18286869 |
| 25 | positive regulation of synapse assembly (GO:0051965) | 3.08843837 |
| 26 | mesenchymal cell proliferation (GO:0010463) | 3.07535013 |
| 27 | embryonic digestive tract morphogenesis (GO:0048557) | 3.07419945 |
| 28 | nephron epithelium morphogenesis (GO:0072088) | 3.06313646 |
| 29 | nephron tubule morphogenesis (GO:0072078) | 3.06313646 |
| 30 | artery development (GO:0060840) | 3.06122970 |
| 31 | hindbrain development (GO:0030902) | 3.05250851 |
| 32 | synaptic vesicle exocytosis (GO:0016079) | 3.04973196 |
| 33 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.04135511 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 3.01485433 |
| 35 | thalamus development (GO:0021794) | 3.00285866 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.00009493 |
| 37 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.98317521 |
| 38 | regulation of fever generation (GO:0031620) | 2.97640881 |
| 39 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.96815233 |
| 40 | plasma membrane repair (GO:0001778) | 2.92300336 |
| 41 | regulation of mesoderm development (GO:2000380) | 2.92051962 |
| 42 | renal system development (GO:0072001) | 2.92003470 |
| 43 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.91866619 |
| 44 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.91522199 |
| 45 | dorsal/ventral axis specification (GO:0009950) | 2.91040037 |
| 46 | neuron recognition (GO:0008038) | 2.90663426 |
| 47 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.89418134 |
| 48 | regulation of glutamate secretion (GO:0014048) | 2.89409837 |
| 49 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.89190806 |
| 50 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.89058812 |
| 51 | phagosome maturation (GO:0090382) | 2.88916174 |
| 52 | dopaminergic neuron differentiation (GO:0071542) | 2.86799800 |
| 53 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.86764161 |
| 54 | negative regulation of protein localization to cell surface (GO:2000009) | 2.85772309 |
| 55 | notochord development (GO:0030903) | 2.85616256 |
| 56 | positive regulation of heat generation (GO:0031652) | 2.85515960 |
| 57 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.84999062 |
| 58 | neural crest cell development (GO:0014032) | 2.83054639 |
| 59 | regulation of timing of cell differentiation (GO:0048505) | 2.82625156 |
| 60 | regulation of development, heterochronic (GO:0040034) | 2.81570192 |
| 61 | midbrain development (GO:0030901) | 2.81037952 |
| 62 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.80702927 |
| 63 | axonal fasciculation (GO:0007413) | 2.80036593 |
| 64 | cell proliferation involved in kidney development (GO:0072111) | 2.75440157 |
| 65 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.74215000 |
| 66 | renal tubule morphogenesis (GO:0061333) | 2.74207415 |
| 67 | glomerulus development (GO:0032835) | 2.73883182 |
| 68 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.73715359 |
| 69 | regulation of sarcomere organization (GO:0060297) | 2.72137832 |
| 70 | establishment of planar polarity (GO:0001736) | 2.72055440 |
| 71 | establishment of tissue polarity (GO:0007164) | 2.72055440 |
| 72 | lung-associated mesenchyme development (GO:0060484) | 2.71717068 |
| 73 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.71580676 |
| 74 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.71580676 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.70763219 |
| 76 | eosinophil chemotaxis (GO:0048245) | 2.70694300 |
| 77 | regulation of synapse maturation (GO:0090128) | 2.69235644 |
| 78 | superoxide anion generation (GO:0042554) | 2.68307634 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68224930 |
| 80 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.67026458 |
| 81 | primitive streak formation (GO:0090009) | 2.66920445 |
| 82 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.66634303 |
| 83 | intraciliary transport (GO:0042073) | 2.66198838 |
| 84 | transferrin transport (GO:0033572) | 2.65596937 |
| 85 | male genitalia development (GO:0030539) | 2.63992429 |
| 86 | radial glial cell differentiation (GO:0060019) | 2.63411072 |
| 87 | regulation of synapse assembly (GO:0051963) | 2.61988206 |
| 88 | positive regulation of gastrulation (GO:2000543) | 2.61970241 |
| 89 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.61414631 |
| 90 | cell proliferation involved in metanephros development (GO:0072203) | 2.60866218 |
| 91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.60666526 |
| 92 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.58926176 |
| 93 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.58868729 |
| 94 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.58301909 |
| 95 | forebrain neuron differentiation (GO:0021879) | 2.57796169 |
| 96 | glutamate receptor signaling pathway (GO:0007215) | 2.57462724 |
| 97 | ectoderm development (GO:0007398) | 2.57290848 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54890042 |
| 99 | pericardium development (GO:0060039) | 2.54854147 |
| 100 | positive regulation of macrophage cytokine production (GO:0060907) | 2.54290072 |
| 101 | negative regulation of epidermis development (GO:0045683) | 2.53928557 |
| 102 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.53682531 |
| 103 | limb bud formation (GO:0060174) | 2.52773491 |
| 104 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.52240749 |
| 105 | cerebellar granule cell differentiation (GO:0021707) | 2.52084899 |
| 106 | epithelial cilium movement (GO:0003351) | 2.51482214 |
| 107 | facial nerve structural organization (GO:0021612) | 2.51131811 |
| 108 | embryonic pattern specification (GO:0009880) | 2.50368551 |
| 109 | somite rostral/caudal axis specification (GO:0032525) | 2.50211557 |
| 110 | negative regulation of axon guidance (GO:1902668) | 2.50052979 |
| 111 | gastrulation with mouth forming second (GO:0001702) | 2.49994258 |
| 112 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49854701 |
| 113 | cardiac right ventricle morphogenesis (GO:0003215) | 2.49828842 |
| 114 | paraxial mesoderm development (GO:0048339) | 2.49459020 |
| 115 | regulation of keratinocyte proliferation (GO:0010837) | 2.49374311 |
| 116 | positive regulation of embryonic development (GO:0040019) | 2.48939923 |
| 117 | negative regulation of mast cell activation (GO:0033004) | 2.48833984 |
| 118 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.48707624 |
| 119 | regulation of mononuclear cell migration (GO:0071675) | 2.47483039 |
| 120 | positive regulation of type 2 immune response (GO:0002830) | 2.47383008 |
| 121 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.47243550 |
| 122 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.46916571 |
| 123 | neuron-neuron synaptic transmission (GO:0007270) | 2.45981600 |
| 124 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.45612547 |
| 125 | regulation of axon guidance (GO:1902667) | 2.44198740 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.43751124 |
| 127 | ferric iron transport (GO:0015682) | 2.43030166 |
| 128 | trivalent inorganic cation transport (GO:0072512) | 2.43030166 |
| 129 | regulation of cardioblast differentiation (GO:0051890) | 2.42821912 |
| 130 | positive regulation of actin filament depolymerization (GO:0030836) | 2.42154888 |
| 131 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.41408474 |
| 132 | glial cell proliferation (GO:0014009) | 2.41307564 |
| 133 | locomotory exploration behavior (GO:0035641) | 2.40333468 |
| 134 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.40121133 |
| 135 | smoothened signaling pathway (GO:0007224) | 2.39325801 |
| 136 | regulation of amino acid transport (GO:0051955) | 2.39115178 |
| 137 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.38396912 |
| 138 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.38396912 |
| 139 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.37635145 |
| 140 | synaptic transmission, glutamatergic (GO:0035249) | 2.37390475 |
| 141 | startle response (GO:0001964) | 2.37307121 |
| 142 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.37089520 |
| 143 | genitalia morphogenesis (GO:0035112) | 2.37001478 |
| 144 | cholesterol biosynthetic process (GO:0006695) | 2.36478396 |
| 145 | response to histamine (GO:0034776) | 2.36114081 |
| 146 | wound healing, spreading of epidermal cells (GO:0035313) | 2.36005443 |
| 147 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.35737410 |
| 148 | pancreas development (GO:0031016) | 2.35619194 |
| 149 | neural tube formation (GO:0001841) | 2.35426401 |
| 150 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.34909397 |
| 151 | lung epithelium development (GO:0060428) | 2.34355978 |
| 152 | sympathetic nervous system development (GO:0048485) | 2.33998569 |
| 153 | negative regulation of interleukin-17 production (GO:0032700) | 2.33560127 |
| 154 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.32786544 |
| 155 | positive regulation of interleukin-6 production (GO:0032755) | 2.32360186 |
| 156 | cellular response to cholesterol (GO:0071397) | 2.31913048 |
| 157 | endocardial cushion morphogenesis (GO:0003203) | 2.31736906 |
| 158 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.31587228 |
| 159 | eosinophil migration (GO:0072677) | 2.30702544 |
| 160 | reproductive system development (GO:0061458) | 2.30628354 |
| 161 | glutamate secretion (GO:0014047) | 2.30623305 |
| 162 | neutrophil activation involved in immune response (GO:0002283) | 2.30114228 |
| 163 | DNA integration (GO:0015074) | 2.30084539 |
| 164 | negative regulation of exocytosis (GO:0045920) | 2.30035011 |
| 165 | hindlimb morphogenesis (GO:0035137) | 2.29973931 |
| 166 | embryonic axis specification (GO:0000578) | 2.29694657 |
| 167 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.29603444 |
| 168 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.29265906 |
| 169 | organ formation (GO:0048645) | 2.27787022 |
| 170 | regulation of action potential (GO:0098900) | 2.26901944 |
| 171 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.26535664 |
| 172 | mesenchyme morphogenesis (GO:0072132) | 2.26377262 |
| 173 | negative regulation of axon extension (GO:0030517) | 2.26185980 |
| 174 | long-term synaptic potentiation (GO:0060291) | 2.24947975 |
| 175 | histamine secretion (GO:0001821) | 2.23228133 |
| 176 | auditory behavior (GO:0031223) | 2.21101851 |
| 177 | exploration behavior (GO:0035640) | 2.20184043 |
| 178 | positive regulation of calcium ion import (GO:0090280) | 2.19622175 |
| 179 | cranial nerve structural organization (GO:0021604) | 2.19528432 |
| 180 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.18184831 |
| 181 | detection of other organism (GO:0098543) | 2.16364237 |
| 182 | regulation of chemokine biosynthetic process (GO:0045073) | 2.15883576 |
| 183 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.15637090 |
| 184 | regulation of synapse organization (GO:0050807) | 2.15464014 |
| 185 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.11765433 |
| 186 | modulation by symbiont of host immune response (GO:0052553) | 2.11765433 |
| 187 | modulation by symbiont of host defense response (GO:0052031) | 2.11765433 |
| 188 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.11765433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.64494116 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.54145563 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88203054 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.69105727 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.67112086 |
| 6 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.66918543 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.65589659 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.60627687 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54433416 |
| 10 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.54049400 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53204319 |
| 12 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.47712093 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42829526 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.32938260 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.32938260 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.32129128 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31133664 |
| 18 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.31042050 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30575781 |
| 20 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.28579326 |
| 21 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07670098 |
| 22 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.06592837 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.06104662 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.05288410 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01675379 |
| 26 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.99070134 |
| 27 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.95638509 |
| 28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93409499 |
| 29 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.93219351 |
| 30 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.92824591 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86926083 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82999570 |
| 33 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.81785475 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.81558304 |
| 35 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.78446806 |
| 36 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.75675635 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74588784 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73925610 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72278457 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69807164 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68375138 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.67142928 |
| 43 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.66898814 |
| 44 | FUS_26573619_Chip-Seq_HEK293_Human | 1.62372898 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.59756039 |
| 46 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.56585518 |
| 47 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.56309713 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54543959 |
| 49 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.54199669 |
| 50 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.50692313 |
| 51 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49222200 |
| 52 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.48178712 |
| 53 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.46039592 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.45987469 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45941801 |
| 56 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43115018 |
| 57 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41198642 |
| 58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.39609493 |
| 59 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.38421549 |
| 60 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36227459 |
| 61 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.34744405 |
| 62 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.34326945 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.34097984 |
| 64 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.34097984 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34061113 |
| 66 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33555705 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.32476790 |
| 68 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.31501253 |
| 69 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30335361 |
| 70 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.29663779 |
| 71 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.29364140 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.28067319 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27885467 |
| 74 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27161038 |
| 75 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.25906796 |
| 76 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.25789928 |
| 77 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25286819 |
| 78 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.24500039 |
| 79 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.23379708 |
| 80 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.22434445 |
| 81 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.22153606 |
| 82 | RXR_22108803_ChIP-Seq_LS180_Human | 1.22059931 |
| 83 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22003428 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21836856 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21836856 |
| 86 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21545346 |
| 87 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20767085 |
| 88 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20332213 |
| 89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19902429 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17365654 |
| 91 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16775776 |
| 92 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16635456 |
| 93 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.16456016 |
| 94 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.15884457 |
| 95 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.14350874 |
| 96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13242298 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10777784 |
| 98 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.10548148 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10364039 |
| 100 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10038343 |
| 101 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10038343 |
| 102 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09810102 |
| 103 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08511772 |
| 104 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.08318203 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08245074 |
| 106 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07806214 |
| 107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07723779 |
| 108 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06019863 |
| 109 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05237253 |
| 110 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05136397 |
| 111 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05038106 |
| 112 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04829689 |
| 113 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04018231 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 1.03966195 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03917379 |
| 116 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.03548467 |
| 117 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02933864 |
| 118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02249480 |
| 119 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01755524 |
| 120 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01401035 |
| 121 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01346840 |
| 122 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.01176254 |
| 123 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01175186 |
| 124 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.00414517 |
| 125 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.99505715 |
| 126 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.98961371 |
| 127 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97828521 |
| 128 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97410052 |
| 129 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96284571 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.09046487 |
| 2 | MP0000566_synostosis | 3.33107819 |
| 3 | MP0001188_hyperpigmentation | 3.15629994 |
| 4 | MP0003122_maternal_imprinting | 3.06282361 |
| 5 | MP0005171_absent_coat_pigmentation | 2.90173906 |
| 6 | MP0003283_abnormal_digestive_organ | 2.81537580 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 2.67924033 |
| 8 | MP0002234_abnormal_pharynx_morphology | 2.67696718 |
| 9 | MP0003303_peritoneal_inflammation | 2.62122691 |
| 10 | MP0003890_abnormal_embryonic-extraembry | 2.55003168 |
| 11 | MP0005248_abnormal_Harderian_gland | 2.43408446 |
| 12 | MP0003136_yellow_coat_color | 2.31378791 |
| 13 | MP0003941_abnormal_skin_development | 2.29738229 |
| 14 | MP0009046_muscle_twitch | 2.18722443 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.14931909 |
| 16 | MP0001293_anophthalmia | 2.12874581 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.11879255 |
| 18 | MP0009745_abnormal_behavioral_response | 2.11643560 |
| 19 | MP0000383_abnormal_hair_follicle | 2.05818854 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.05544529 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.05534844 |
| 22 | MP0005499_abnormal_olfactory_system | 2.03350137 |
| 23 | MP0004133_heterotaxia | 1.97211427 |
| 24 | MP0002063_abnormal_learning/memory/cond | 1.96881910 |
| 25 | MP0010030_abnormal_orbit_morphology | 1.89688845 |
| 26 | MP0003119_abnormal_digestive_system | 1.86088462 |
| 27 | MP0000778_abnormal_nervous_system | 1.83502940 |
| 28 | MP0002064_seizures | 1.80197675 |
| 29 | MP0006292_abnormal_olfactory_placode | 1.79419323 |
| 30 | MP0002697_abnormal_eye_size | 1.79357714 |
| 31 | MP0009379_abnormal_foot_pigmentation | 1.76870453 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.70498135 |
| 33 | MP0000467_abnormal_esophagus_morphology | 1.70372399 |
| 34 | MP0002736_abnormal_nociception_after | 1.69703759 |
| 35 | MP0001286_abnormal_eye_development | 1.64000877 |
| 36 | MP0001984_abnormal_olfaction | 1.62652047 |
| 37 | MP0002572_abnormal_emotion/affect_behav | 1.61215279 |
| 38 | MP0002163_abnormal_gland_morphology | 1.56241612 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.53399650 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.51223603 |
| 41 | * MP0003385_abnormal_body_wall | 1.48273678 |
| 42 | MP0002184_abnormal_innervation | 1.47527625 |
| 43 | * MP0004272_abnormal_basement_membrane | 1.46717474 |
| 44 | MP0003950_abnormal_plasma_membrane | 1.43852904 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.43733151 |
| 46 | MP0003121_genomic_imprinting | 1.42389231 |
| 47 | MP0005377_hearing/vestibular/ear_phenot | 1.41516320 |
| 48 | MP0003878_abnormal_ear_physiology | 1.41516320 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.40238979 |
| 50 | MP0002751_abnormal_autonomic_nervous | 1.31157913 |
| 51 | MP0004270_analgesia | 1.29691365 |
| 52 | MP0003315_abnormal_perineum_morphology | 1.29646000 |
| 53 | MP0004782_abnormal_surfactant_physiolog | 1.29617499 |
| 54 | MP0002102_abnormal_ear_morphology | 1.28404620 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.27801501 |
| 56 | MP0003828_pulmonary_edema | 1.26838386 |
| 57 | MP0004858_abnormal_nervous_system | 1.26763846 |
| 58 | MP0003935_abnormal_craniofacial_develop | 1.26587127 |
| 59 | MP0000462_abnormal_digestive_system | 1.24389771 |
| 60 | MP0003724_increased_susceptibility_to | 1.24129251 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.23494287 |
| 62 | MP0001346_abnormal_lacrimal_gland | 1.23220032 |
| 63 | MP0001440_abnormal_grooming_behavior | 1.21665464 |
| 64 | MP0002734_abnormal_mechanical_nocicepti | 1.19897010 |
| 65 | MP0002928_abnormal_bile_duct | 1.19700352 |
| 66 | MP0000049_abnormal_middle_ear | 1.18889852 |
| 67 | MP0002938_white_spotting | 1.17895788 |
| 68 | MP0001486_abnormal_startle_reflex | 1.16418918 |
| 69 | MP0002067_abnormal_sensory_capabilities | 1.15696983 |
| 70 | MP0000579_abnormal_nail_morphology | 1.15104089 |
| 71 | MP0003787_abnormal_imprinting | 1.13748505 |
| 72 | MP0005187_abnormal_penis_morphology | 1.13044413 |
| 73 | MP0000631_abnormal_neuroendocrine_gland | 1.12416232 |
| 74 | MP0002092_abnormal_eye_morphology | 1.11833169 |
| 75 | MP0002098_abnormal_vibrissa_morphology | 1.11029798 |
| 76 | MP0002557_abnormal_social/conspecific_i | 1.10987501 |
| 77 | MP0009250_abnormal_appendicular_skeleto | 1.09672636 |
| 78 | MP0002638_abnormal_pupillary_reflex | 1.09517349 |
| 79 | MP0003755_abnormal_palate_morphology | 1.08873598 |
| 80 | MP0002282_abnormal_trachea_morphology | 1.07350962 |
| 81 | MP0001485_abnormal_pinna_reflex | 1.03991419 |
| 82 | MP0009053_abnormal_anal_canal | 1.03603904 |
| 83 | MP0004811_abnormal_neuron_physiology | 1.03583848 |
| 84 | MP0000428_abnormal_craniofacial_morphol | 1.02541869 |
| 85 | MP0000537_abnormal_urethra_morphology | 1.02317386 |
| 86 | MP0000516_abnormal_urinary_system | 1.01709824 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 1.01709824 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 1.01452468 |
| 89 | MP0002272_abnormal_nervous_system | 1.00649252 |
| 90 | MP0004885_abnormal_endolymph | 1.00068474 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.99987588 |
| 92 | MP0000762_abnormal_tongue_morphology | 0.99956940 |
| 93 | MP0003436_decreased_susceptibility_to | 0.98733220 |
| 94 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98702593 |
| 95 | * MP0003861_abnormal_nervous_system | 0.95427722 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.94881946 |
| 97 | MP0005275_abnormal_skin_tensile | 0.94044393 |
| 98 | MP0000647_abnormal_sebaceous_gland | 0.93527117 |
| 99 | MP0005391_vision/eye_phenotype | 0.93290635 |
| 100 | MP0003115_abnormal_respiratory_system | 0.93102720 |
| 101 | MP0003123_paternal_imprinting | 0.92804354 |
| 102 | MP0002177_abnormal_outer_ear | 0.91624543 |
| 103 | MP0001177_atelectasis | 0.91452017 |
| 104 | MP0003942_abnormal_urinary_system | 0.91295524 |
| 105 | MP0002254_reproductive_system_inflammat | 0.90828056 |
| 106 | MP0009785_altered_susceptibility_to | 0.88787062 |
| 107 | MP0004742_abnormal_vestibular_system | 0.88124844 |
| 108 | MP0001970_abnormal_pain_threshold | 0.87813738 |
| 109 | MP0002111_abnormal_tail_morphology | 0.86367201 |
| 110 | MP0002653_abnormal_ependyma_morphology | 0.86068599 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.85606472 |
| 112 | MP0000955_abnormal_spinal_cord | 0.85560376 |
| 113 | MP0000432_abnormal_head_morphology | 0.85293860 |
| 114 | MP0001529_abnormal_vocalization | 0.84559606 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.84419792 |
| 116 | MP0005645_abnormal_hypothalamus_physiol | 0.83056804 |
| 117 | MP0002109_abnormal_limb_morphology | 0.82152155 |
| 118 | MP0002932_abnormal_joint_morphology | 0.81736675 |
| 119 | MP0008995_early_reproductive_senescence | 0.80969279 |
| 120 | MP0002233_abnormal_nose_morphology | 0.80439892 |
| 121 | MP0000534_abnormal_ureter_morphology | 0.78826093 |
| 122 | * MP0002084_abnormal_developmental_patter | 0.78767673 |
| 123 | MP0001340_abnormal_eyelid_morphology | 0.78515568 |
| 124 | MP0002249_abnormal_larynx_morphology | 0.78457396 |
| 125 | MP0003938_abnormal_ear_development | 0.78109954 |
| 126 | MP0001958_emphysema | 0.77207827 |
| 127 | MP0003448_altered_tumor_morphology | 0.75634994 |
| 128 | MP0002752_abnormal_somatic_nervous | 0.75523669 |
| 129 | MP0009764_decreased_sensitivity_to | 0.75283307 |
| 130 | MP0005623_abnormal_meninges_morphology | 0.73992351 |
| 131 | MP0001835_abnormal_antigen_presentation | 0.73941795 |
| 132 | MP0005195_abnormal_posterior_eye | 0.73541316 |
| 133 | MP0002882_abnormal_neuron_morphology | 0.72916827 |
| 134 | MP0005000_abnormal_immune_tolerance | 0.71927397 |
| 135 | MP0002152_abnormal_brain_morphology | 0.71541376 |
| 136 | MP0000538_abnormal_urinary_bladder | 0.71478484 |
| 137 | MP0000026_abnormal_inner_ear | 0.70985260 |
| 138 | MP0009384_cardiac_valve_regurgitation | 0.69554562 |
| 139 | MP0002116_abnormal_craniofacial_bone | 0.69400929 |
| 140 | MP0004883_abnormal_blood_vessel | 0.69364531 |
| 141 | MP0004924_abnormal_behavior | 0.69322958 |
| 142 | MP0005386_behavior/neurological_phenoty | 0.69322958 |
| 143 | MP0000015_abnormal_ear_pigmentation | 0.69060517 |
| 144 | MP0009703_decreased_birth_body | 0.69005300 |
| 145 | MP0003937_abnormal_limbs/digits/tail_de | 0.68989462 |
| 146 | MP0008789_abnormal_olfactory_epithelium | 0.68802780 |
| 147 | MP0005167_abnormal_blood-brain_barrier | 0.68433563 |
| 148 | MP0008004_abnormal_stomach_pH | 0.68173642 |
| 149 | MP0005394_taste/olfaction_phenotype | 0.67889877 |
| 150 | MP0004264_abnormal_extraembryonic_tissu | 0.67439982 |
| 151 | MP0002081_perinatal_lethality | 0.66925499 |
| 152 | MP0004215_abnormal_myocardial_fiber | 0.66919482 |
| 153 | MP0005253_abnormal_eye_physiology | 0.66740812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.20640168 |
| 2 | Atonic seizures (HP:0010819) | 3.72263973 |
| 3 | Epileptic encephalopathy (HP:0200134) | 3.64733247 |
| 4 | Febrile seizures (HP:0002373) | 3.64560721 |
| 5 | Hyperventilation (HP:0002883) | 3.41046546 |
| 6 | True hermaphroditism (HP:0010459) | 3.11906175 |
| 7 | Hypoplastic labia majora (HP:0000059) | 3.01733674 |
| 8 | Abnormality of the nasal septum (HP:0000419) | 2.97247067 |
| 9 | Bilateral microphthalmos (HP:0007633) | 2.89295304 |
| 10 | Esophageal atresia (HP:0002032) | 2.85996583 |
| 11 | Absence seizures (HP:0002121) | 2.81934585 |
| 12 | Septo-optic dysplasia (HP:0100842) | 2.81330494 |
| 13 | Focal seizures (HP:0007359) | 2.79024674 |
| 14 | Hypoplastic female external genitalia (HP:0012815) | 2.75360951 |
| 15 | Aplasia cutis congenita (HP:0001057) | 2.70747720 |
| 16 | Abnormality of the labia majora (HP:0012881) | 2.68703963 |
| 17 | Myokymia (HP:0002411) | 2.62380484 |
| 18 | Dialeptic seizures (HP:0011146) | 2.59755251 |
| 19 | Abnormality of incisor morphology (HP:0011063) | 2.59554674 |
| 20 | Hepatoblastoma (HP:0002884) | 2.57821047 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 2.56855282 |
| 22 | Abnormal hair whorl (HP:0010721) | 2.56059496 |
| 23 | Bifid tongue (HP:0010297) | 2.50158483 |
| 24 | Onycholysis (HP:0001806) | 2.49294314 |
| 25 | Anterior segment dysgenesis (HP:0007700) | 2.47986610 |
| 26 | Calf muscle hypertrophy (HP:0008981) | 2.46773437 |
| 27 | Absent speech (HP:0001344) | 2.46451314 |
| 28 | Conical tooth (HP:0000698) | 2.46194347 |
| 29 | Preaxial foot polydactyly (HP:0001841) | 2.45491428 |
| 30 | Prostate neoplasm (HP:0100787) | 2.45293778 |
| 31 | Milia (HP:0001056) | 2.44106822 |
| 32 | Hypoplastic pelvis (HP:0008839) | 2.44078318 |
| 33 | Thick nail (HP:0001805) | 2.42476640 |
| 34 | Gastrointestinal atresia (HP:0002589) | 2.38286479 |
| 35 | Alacrima (HP:0000522) | 2.36816521 |
| 36 | Midline defect of the nose (HP:0004122) | 2.36376797 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.35935089 |
| 38 | Stomach cancer (HP:0012126) | 2.35718556 |
| 39 | Heterochromia iridis (HP:0001100) | 2.34800929 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.34131867 |
| 41 | Absent eyebrow (HP:0002223) | 2.33755118 |
| 42 | Pancreatic cysts (HP:0001737) | 2.33497915 |
| 43 | Intestinal atresia (HP:0011100) | 2.32531344 |
| 44 | Cerebellar dysplasia (HP:0007033) | 2.32311595 |
| 45 | Oligodactyly (hands) (HP:0001180) | 2.31658925 |
| 46 | Optic neuritis (HP:0100653) | 2.31097659 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.31097659 |
| 48 | Renal hypoplasia (HP:0000089) | 2.30862201 |
| 49 | Tubular atrophy (HP:0000092) | 2.30588486 |
| 50 | Abnormality of the ischium (HP:0003174) | 2.29116593 |
| 51 | Narrow nasal bridge (HP:0000446) | 2.28485609 |
| 52 | Broad-based gait (HP:0002136) | 2.28368686 |
| 53 | Decreased lacrimation (HP:0000633) | 2.26299936 |
| 54 | Pancreatic fibrosis (HP:0100732) | 2.25422748 |
| 55 | Chronic hepatic failure (HP:0100626) | 2.24154744 |
| 56 | Inability to walk (HP:0002540) | 2.23419243 |
| 57 | Exercise-induced muscle cramps (HP:0003710) | 2.21948334 |
| 58 | Atrophic scars (HP:0001075) | 2.17274301 |
| 59 | Abnormality of the nasolacrimal system (HP:0000614) | 2.14606499 |
| 60 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.14033529 |
| 61 | Increased number of teeth (HP:0011069) | 2.13751653 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.13197043 |
| 63 | Split foot (HP:0001839) | 2.12085278 |
| 64 | Coronal craniosynostosis (HP:0004440) | 2.11079052 |
| 65 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.10671322 |
| 66 | Parakeratosis (HP:0001036) | 2.10632349 |
| 67 | Abnormality of nail color (HP:0100643) | 2.08477525 |
| 68 | Short tibia (HP:0005736) | 2.08267782 |
| 69 | Drooling (HP:0002307) | 2.07983541 |
| 70 | Excessive salivation (HP:0003781) | 2.07983541 |
| 71 | Abnormality of the lacrimal duct (HP:0011481) | 2.07654446 |
| 72 | Failure to thrive in infancy (HP:0001531) | 2.06880582 |
| 73 | Gait imbalance (HP:0002141) | 2.06711175 |
| 74 | Maternal diabetes (HP:0009800) | 2.06236038 |
| 75 | Thickened helices (HP:0000391) | 2.05739804 |
| 76 | Nephronophthisis (HP:0000090) | 2.05356269 |
| 77 | Abnormality of salivation (HP:0100755) | 2.04512651 |
| 78 | Congenital sensorineural hearing impairment (HP:0008527) | 2.04001143 |
| 79 | Tubulointerstitial abnormality (HP:0001969) | 2.02288810 |
| 80 | Choroideremia (HP:0001139) | 2.01818694 |
| 81 | Molar tooth sign on MRI (HP:0002419) | 2.00420780 |
| 82 | Abnormality of midbrain morphology (HP:0002418) | 2.00420780 |
| 83 | Tubulointerstitial fibrosis (HP:0005576) | 1.98272547 |
| 84 | Congenital primary aphakia (HP:0007707) | 1.97709465 |
| 85 | Xerostomia (HP:0000217) | 1.97570872 |
| 86 | Generalized tonic-clonic seizures (HP:0002069) | 1.96884215 |
| 87 | Vaginal atresia (HP:0000148) | 1.95643934 |
| 88 | Abnormality of the renal medulla (HP:0100957) | 1.94516702 |
| 89 | Protruding tongue (HP:0010808) | 1.94473956 |
| 90 | Medial flaring of the eyebrow (HP:0010747) | 1.94293340 |
| 91 | Papillary thyroid carcinoma (HP:0002895) | 1.93418494 |
| 92 | Vitreoretinal degeneration (HP:0000655) | 1.93093379 |
| 93 | Plantar hyperkeratosis (HP:0007556) | 1.92971084 |
| 94 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.92484766 |
| 95 | Orchitis (HP:0100796) | 1.91036630 |
| 96 | Nasolacrimal duct obstruction (HP:0000579) | 1.90515701 |
| 97 | Epidermoid cyst (HP:0200040) | 1.88632118 |
| 98 | Abnormality of the renal cortex (HP:0011035) | 1.87384002 |
| 99 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.87082176 |
| 100 | Aplasia of the phalanges of the hand (HP:0009802) | 1.87082176 |
| 101 | Aplasia involving bones of the extremities (HP:0009825) | 1.87082176 |
| 102 | Cutaneous syndactyly (HP:0012725) | 1.85440083 |
| 103 | Genital tract atresia (HP:0001827) | 1.85433027 |
| 104 | Optic nerve hypoplasia (HP:0000609) | 1.85138064 |
| 105 | Specific learning disability (HP:0001328) | 1.85083026 |
| 106 | Postaxial hand polydactyly (HP:0001162) | 1.84207107 |
| 107 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.83963198 |
| 108 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.82628167 |
| 109 | Vertebral hypoplasia (HP:0008417) | 1.82628167 |
| 110 | Tubulointerstitial nephritis (HP:0001970) | 1.82547901 |
| 111 | Abnormality of the labia (HP:0000058) | 1.81977881 |
| 112 | Cutaneous finger syndactyly (HP:0010554) | 1.81650343 |
| 113 | Bicornuate uterus (HP:0000813) | 1.80442484 |
| 114 | Amblyopia (HP:0000646) | 1.79368425 |
| 115 | Recurrent corneal erosions (HP:0000495) | 1.78799258 |
| 116 | Limb dystonia (HP:0002451) | 1.78484552 |
| 117 | Disproportionate short-trunk short stature (HP:0003521) | 1.78395010 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78179034 |
| 119 | Exotropia (HP:0000577) | 1.77658251 |
| 120 | Anophthalmia (HP:0000528) | 1.76417362 |
| 121 | Postaxial foot polydactyly (HP:0001830) | 1.76132300 |
| 122 | Myelomeningocele (HP:0002475) | 1.76118706 |
| 123 | Progressive inability to walk (HP:0002505) | 1.76044742 |
| 124 | Renal cortical cysts (HP:0000803) | 1.74885262 |
| 125 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.74697411 |
| 126 | Recurrent bacterial skin infections (HP:0005406) | 1.74096421 |
| 127 | Popliteal pterygium (HP:0009756) | 1.73893397 |
| 128 | Alveolar cell carcinoma (HP:0006519) | 1.73723259 |
| 129 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.73192992 |
| 130 | Right ventricular cardiomyopathy (HP:0011663) | 1.73054309 |
| 131 | Broad toe (HP:0001837) | 1.71393621 |
| 132 | Hypodontia (HP:0000668) | 1.70800757 |
| 133 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.70569666 |
| 134 | Hip dysplasia (HP:0001385) | 1.70395695 |
| 135 | Arterial tortuosity (HP:0005116) | 1.70122844 |
| 136 | Oligodactyly (HP:0012165) | 1.69638447 |
| 137 | Absent septum pellucidum (HP:0001331) | 1.69443989 |
| 138 | Concave nail (HP:0001598) | 1.68680521 |
| 139 | Ulnar claw (HP:0001178) | 1.68425510 |
| 140 | Humeroradial synostosis (HP:0003041) | 1.68305261 |
| 141 | Synostosis involving the elbow (HP:0003938) | 1.68305261 |
| 142 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.68243936 |
| 143 | Cystic liver disease (HP:0006706) | 1.68072207 |
| 144 | Sclerocornea (HP:0000647) | 1.67632144 |
| 145 | Anal stenosis (HP:0002025) | 1.66955283 |
| 146 | Cupped ear (HP:0000378) | 1.66670394 |
| 147 | Polyphagia (HP:0002591) | 1.66524734 |
| 148 | Morphological abnormality of the middle ear (HP:0008609) | 1.66468658 |
| 149 | Intellectual disability, moderate (HP:0002342) | 1.65890284 |
| 150 | Shoulder girdle muscle weakness (HP:0003547) | 1.65876498 |
| 151 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.65610596 |
| 152 | Anhidrosis (HP:0000970) | 1.65363838 |
| 153 | Long nose (HP:0003189) | 1.65187671 |
| 154 | Stomatitis (HP:0010280) | 1.65141925 |
| 155 | Labial hypoplasia (HP:0000066) | 1.64860851 |
| 156 | Growth hormone deficiency (HP:0000824) | 1.64211632 |
| 157 | Porencephaly (HP:0002132) | 1.63726419 |
| 158 | Neoplasm of the adrenal cortex (HP:0100641) | 1.63558609 |
| 159 | Bronchomalacia (HP:0002780) | 1.62372245 |
| 160 | Hypoplasia of the ulna (HP:0003022) | 1.59743212 |
| 161 | Abnormality of the labia minora (HP:0012880) | 1.59621465 |
| 162 | Uterine leiomyosarcoma (HP:0002891) | 1.59113176 |
| 163 | Leiomyosarcoma (HP:0100243) | 1.59113176 |
| 164 | Fragile nails (HP:0001808) | 1.59000628 |
| 165 | Occipital encephalocele (HP:0002085) | 1.58986445 |
| 166 | Mixed hearing impairment (HP:0000410) | 1.58844286 |
| 167 | Preaxial hand polydactyly (HP:0001177) | 1.58832405 |
| 168 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.58678753 |
| 169 | Short 4th metacarpal (HP:0010044) | 1.58678753 |
| 170 | Severe Myopia (HP:0011003) | 1.58361046 |
| 171 | Oligodontia (HP:0000677) | 1.57838922 |
| 172 | Hyperglycinemia (HP:0002154) | 1.57544670 |
| 173 | Asymmetry of the thorax (HP:0001555) | 1.56412724 |
| 174 | Aqueductal stenosis (HP:0002410) | 1.56266102 |
| 175 | Subacute progressive viral hepatitis (HP:0006572) | 1.55057773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 7.37861655 |
| 2 | PNCK | 3.69561382 |
| 3 | EPHB2 | 2.83610023 |
| 4 | RIPK4 | 2.82541239 |
| 5 | MAP3K12 | 2.72881385 |
| 6 | EPHA4 | 2.63609342 |
| 7 | SIK3 | 2.55583844 |
| 8 | PLK2 | 2.47709236 |
| 9 | MAPK15 | 2.38370450 |
| 10 | MAP3K14 | 2.25964004 |
| 11 | BCR | 2.24702799 |
| 12 | AKT3 | 2.19222723 |
| 13 | NTRK3 | 2.09488411 |
| 14 | WEE1 | 2.01422946 |
| 15 | YES1 | 1.89836966 |
| 16 | MARK1 | 1.89662857 |
| 17 | MAP2K7 | 1.83815537 |
| 18 | PBK | 1.81937706 |
| 19 | KSR1 | 1.77919010 |
| 20 | ERBB3 | 1.72804437 |
| 21 | TRIM28 | 1.66813166 |
| 22 | BRD4 | 1.57807631 |
| 23 | FER | 1.57493355 |
| 24 | MAPKAPK5 | 1.57255311 |
| 25 | BMPR2 | 1.55047412 |
| 26 | EPHA3 | 1.52800518 |
| 27 | FGFR2 | 1.52611089 |
| 28 | MINK1 | 1.49381390 |
| 29 | INSRR | 1.46044320 |
| 30 | DAPK2 | 1.44766406 |
| 31 | TGFBR1 | 1.43563169 |
| 32 | LMTK2 | 1.41769956 |
| 33 | LATS1 | 1.38617166 |
| 34 | NTRK2 | 1.33944410 |
| 35 | PRPF4B | 1.32960644 |
| 36 | MAPK13 | 1.31968568 |
| 37 | BRSK2 | 1.30939027 |
| 38 | PKN2 | 1.30297825 |
| 39 | ACVR1B | 1.29892592 |
| 40 | MAP3K4 | 1.28722081 |
| 41 | ERBB4 | 1.27391111 |
| 42 | FLT3 | 1.27135636 |
| 43 | MAP3K9 | 1.14643811 |
| 44 | MST4 | 1.14576632 |
| 45 | STK38L | 1.10235684 |
| 46 | MET | 1.09389574 |
| 47 | PRKCE | 1.04840923 |
| 48 | PIM2 | 1.03788980 |
| 49 | WNK3 | 1.03147407 |
| 50 | ARAF | 1.02980745 |
| 51 | MST1R | 1.01467187 |
| 52 | BMPR1B | 0.97627158 |
| 53 | CSNK1G1 | 0.94494504 |
| 54 | GRK1 | 0.92044431 |
| 55 | PINK1 | 0.89254562 |
| 56 | FES | 0.88902116 |
| 57 | TAOK2 | 0.88477897 |
| 58 | SGK2 | 0.88361403 |
| 59 | BRAF | 0.87464349 |
| 60 | TYRO3 | 0.87359094 |
| 61 | OBSCN | 0.87164988 |
| 62 | VRK1 | 0.87131533 |
| 63 | NTRK1 | 0.84928115 |
| 64 | CAMK2A | 0.84453029 |
| 65 | CCNB1 | 0.80237083 |
| 66 | SGK223 | 0.79050533 |
| 67 | SGK494 | 0.79050533 |
| 68 | DAPK1 | 0.77940690 |
| 69 | LATS2 | 0.74248224 |
| 70 | FGFR1 | 0.74158282 |
| 71 | ERBB2 | 0.74003455 |
| 72 | CDK8 | 0.73194721 |
| 73 | CHUK | 0.72797207 |
| 74 | MAP4K2 | 0.72704433 |
| 75 | PLK4 | 0.72423467 |
| 76 | BLK | 0.72400802 |
| 77 | DYRK2 | 0.72040809 |
| 78 | PRKCG | 0.70166922 |
| 79 | TBK1 | 0.69166645 |
| 80 | GRK5 | 0.69050005 |
| 81 | EIF2AK2 | 0.68164104 |
| 82 | STK3 | 0.67761817 |
| 83 | IKBKB | 0.67401051 |
| 84 | STK39 | 0.67118782 |
| 85 | CDK5 | 0.66784221 |
| 86 | MAP2K4 | 0.66478166 |
| 87 | FRK | 0.64923049 |
| 88 | CDK3 | 0.63890886 |
| 89 | ADRBK2 | 0.62955178 |
| 90 | BMX | 0.62785019 |
| 91 | NUAK1 | 0.62455987 |
| 92 | LIMK1 | 0.62228891 |
| 93 | PAK3 | 0.62015999 |
| 94 | CDK14 | 0.60204289 |
| 95 | SGK1 | 0.58919411 |
| 96 | DYRK3 | 0.58545808 |
| 97 | TIE1 | 0.56283325 |
| 98 | TSSK6 | 0.55971557 |
| 99 | MAP3K5 | 0.54017321 |
| 100 | CAMK2B | 0.53455999 |
| 101 | ADRBK1 | 0.53316543 |
| 102 | CDK18 | 0.53226832 |
| 103 | PKN1 | 0.52243790 |
| 104 | MUSK | 0.52165064 |
| 105 | NLK | 0.50426197 |
| 106 | FGFR3 | 0.49635481 |
| 107 | PLK3 | 0.49514782 |
| 108 | PDGFRA | 0.49510484 |
| 109 | MAP3K2 | 0.47668050 |
| 110 | CAMK1G | 0.47404635 |
| 111 | MELK | 0.47098756 |
| 112 | PDK2 | 0.46353317 |
| 113 | STK24 | 0.46158954 |
| 114 | ROCK1 | 0.45936779 |
| 115 | EPHA2 | 0.45683614 |
| 116 | TXK | 0.45631221 |
| 117 | PRKACB | 0.45592909 |
| 118 | CDK19 | 0.44846811 |
| 119 | PRKCZ | 0.44673911 |
| 120 | CSNK1A1L | 0.44508808 |
| 121 | PTK2B | 0.43993916 |
| 122 | GRK7 | 0.43147391 |
| 123 | DAPK3 | 0.43136894 |
| 124 | IRAK2 | 0.42139301 |
| 125 | RPS6KA2 | 0.41242045 |
| 126 | TNIK | 0.41108832 |
| 127 | CSNK1G2 | 0.40911733 |
| 128 | FGR | 0.40217162 |
| 129 | PAK6 | 0.40168393 |
| 130 | MAP3K10 | 0.39718816 |
| 131 | OXSR1 | 0.39678071 |
| 132 | CSNK1G3 | 0.39422917 |
| 133 | CSNK1D | 0.38779522 |
| 134 | PIK3CA | 0.38474623 |
| 135 | DMPK | 0.38193833 |
| 136 | MKNK1 | 0.37999938 |
| 137 | MYLK | 0.37935422 |
| 138 | CDK15 | 0.36957073 |
| 139 | UHMK1 | 0.36785297 |
| 140 | ROCK2 | 0.36246419 |
| 141 | NEK9 | 0.31901481 |
| 142 | PRKCD | 0.31838686 |
| 143 | NEK6 | 0.31793664 |
| 144 | IRAK1 | 0.31688203 |
| 145 | MKNK2 | 0.31211957 |
| 146 | DDR2 | 0.30833145 |
| 147 | FYN | 0.30641764 |
| 148 | CAMKK2 | 0.29591342 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.87998523 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.77854665 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.62906326 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.61322029 |
| 5 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.56904207 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.55491174 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.46835417 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09954989 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.09350178 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.02878775 |
| 11 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.96732670 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.90534766 |
| 13 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.90247618 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89231278 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87717761 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.86934153 |
| 17 | Phagosome_Homo sapiens_hsa04145 | 1.76915342 |
| 18 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.70840730 |
| 19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.70764730 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.65686581 |
| 21 | Legionellosis_Homo sapiens_hsa05134 | 1.59832654 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57140716 |
| 23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.49492437 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45932636 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.45145908 |
| 26 | Morphine addiction_Homo sapiens_hsa05032 | 1.44595005 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.44276714 |
| 28 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43177776 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.42577284 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.39443188 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.38004369 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37374390 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.36872209 |
| 34 | Long-term depression_Homo sapiens_hsa04730 | 1.36074847 |
| 35 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35555286 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33043379 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.32144648 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31507663 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.26749694 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24061890 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.24042304 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22735092 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.22524092 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21701406 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21699855 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20618845 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.19649621 |
| 48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.18583595 |
| 49 | Long-term potentiation_Homo sapiens_hsa04720 | 1.18420874 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17228512 |
| 51 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16096601 |
| 52 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15099619 |
| 53 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.14512695 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14374855 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14150862 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13529349 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 1.12684142 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 1.12676250 |
| 59 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12632345 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12552801 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10887189 |
| 62 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.07555004 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07085624 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 1.05038161 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04528011 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04000593 |
| 67 | Asthma_Homo sapiens_hsa05310 | 1.01623456 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.01466674 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.01231238 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 1.00898897 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.99980708 |
| 72 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.98890900 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.96993733 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96670525 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.96513108 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.96426382 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96251634 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95246158 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.95088234 |
| 80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93887227 |
| 81 | Cocaine addiction_Homo sapiens_hsa05030 | 0.93652952 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.92782569 |
| 83 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90993007 |
| 84 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90536667 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.90270371 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.90237766 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.90164512 |
| 88 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.89216875 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.89097528 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87530956 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87438409 |
| 92 | Melanogenesis_Homo sapiens_hsa04916 | 0.87433261 |
| 93 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.86932227 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86373555 |
| 95 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85996194 |
| 96 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85571550 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85420566 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84627365 |
| 99 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83641595 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.82655426 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.80532596 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75363161 |
| 103 | Phototransduction_Homo sapiens_hsa04744 | 0.74606443 |
| 104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.74562924 |
| 105 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74214557 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73988932 |
| 107 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.73852421 |
| 108 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73561807 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73457243 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72893193 |
| 111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72083282 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.71799487 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71347189 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70665227 |
| 115 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69578117 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69348631 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68971188 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.68894428 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68762147 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.67946036 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.67648829 |
| 122 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65483319 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.63507274 |
| 124 | Influenza A_Homo sapiens_hsa05164 | 0.63195193 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.62462800 |
| 126 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.62003911 |
| 127 | Focal adhesion_Homo sapiens_hsa04510 | 0.61875122 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60748067 |
| 129 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.59884053 |
| 130 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59844110 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.59817181 |
| 132 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59512122 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59193282 |
| 134 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59145283 |
| 135 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58271134 |
| 136 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58106143 |
| 137 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58096725 |
| 138 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57994536 |
| 139 | Glioma_Homo sapiens_hsa05214 | 0.57878895 |
| 140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57273392 |
| 141 | Insulin secretion_Homo sapiens_hsa04911 | 0.56943685 |
| 142 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55643481 |
| 143 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54171570 |
| 144 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53692684 |
| 145 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53558352 |
| 146 | Adherens junction_Homo sapiens_hsa04520 | 0.53481808 |
| 147 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.53397863 |
| 148 | Bile secretion_Homo sapiens_hsa04976 | 0.53217904 |
| 149 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52804994 |
| 150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52087307 |
| 151 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51636642 |
| 152 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51216754 |
| 153 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51116792 |
| 154 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50222628 |
| 155 | ABC transporters_Homo sapiens_hsa02010 | 0.49950732 |
| 156 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49843428 |
| 157 | Prion diseases_Homo sapiens_hsa05020 | 0.49227881 |
| 158 | Measles_Homo sapiens_hsa05162 | 0.49036997 |
| 159 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.48799327 |
| 160 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48033643 |
| 161 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47151207 |
| 162 | Mineral absorption_Homo sapiens_hsa04978 | 0.45666411 |
| 163 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45633143 |
| 164 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.44885306 |
| 165 | Lysine degradation_Homo sapiens_hsa00310 | 0.44200447 |
| 166 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43303834 |
| 167 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.42634377 |
| 168 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41845072 |
| 169 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41349758 |
| 170 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40972613 |

